| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001619 |
Purpose
Magnetic resonance imaging (MRI) is a diagnostic tool that creates high quality images of the human body without the use of X-ray (radiation). MRI uses different levels of magnetic fields to create images of the body and organs. Occasionally, researchers will give patients undergoing a MRI an injection of a substance called gadolinium. Gadolinium works by brightening areas of the magnetic resonance image, thereby improving the contrast.
In this study researchers will use magnetic resonance imaging and contrast substances, like gadolinium, on normal volunteers in order to evaluate different aspects of its performance. Information gathered from this study may be used to develop more specific research studies involving MRI.
| Condition |
|
Cardiovascular Disease Healthy |
| Genetics Home Reference related topics: | ataxia-telangiectasia |
| MedlinePlus related topics: | MRI Scans |
| Study Type: | Observational |
| Official Title: | Magnetic Resonance at 1.5 and 3 Tesla |
| Estimated Enrollment: | 600 |
| Study Start Date: | November 1996 |
Technical evaluation of magnetic resonance imaging and spectroscopy will be performed on normal volunteers. These studies will be conducted in the MRI systems located at the NIH. These studies may involve the intravenous administration of commercially available MR contrast media and exercise. The results will be used to evaluate the performance of various pulse sequences, gradient coils, and RF coils on human subjects and will provide essential ground work for specific patient protocols.
Eligibility
| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Any normal volunteer above the age of 18 who is capable of giving informed consent.
EXCLUSION CRITERIA:
A subject will be excluded if he/she has a contraindication to MR scanning such as:
EXCLUSION CRITERIA FOR GADOLINIUM ENHANCED STUDIES:
Contacts and Locations| Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
| Contact: TTY | 1-866-411-1010 |
| United States, Maryland | |||||
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting | ||||
| Bethesda, Maryland, United States, 20892 | |||||
More Information
NIH Clinical Center Detailed Web Page
|
| Study ID Numbers: | 970026, 97-H-0026 |
| First Received: | November 3, 1999 |
| Last Updated: | October 21, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001619 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
